SNY - Mirati Therapeutics soars on report of Sanofi takeover interest
2023-10-05 14:35:52 ET
More on Mirati Therapeutics
- Mirati: Expansion Of Adagrasib With sNDA And Combination Studies
- Mirati Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Mirati Therapeutics, Inc. (MRTX) Q2 2023 Earnings Call Transcript
- Mirati stock up 9% amid FDA meeting on rival Amgen drug (update)
- Jones Research sees Amgen FDA issues reading through to Mirati
For further details see:
Mirati Therapeutics soars on report of Sanofi takeover interest